Brooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits